Sofinnova Partners logo

Sofinnova Partners

Europe, Ile-de-France, France, Paris

Description

Sofinnova Partners is a venture capital firm that invests in the life sciences sector, from seed to later-stage.

Investor Profile

Sofinnova Partners has made 343 investments, with 22 in the past 12 months and 45% as lead.

Stage Focus

  • Series A (34%)
  • Series B (22%)
  • Series C (14%)
  • Seed (10%)
  • Series Unknown (10%)
  • Post Ipo Equity (6%)
  • Series D (4%)
  • Private Equity (1%)

Country Focus

  • France (36%)
  • United States (26%)
  • United Kingdom (12%)
  • Switzerland (6%)
  • Italy (5%)
  • Germany (3%)
  • Belgium (2%)
  • The Netherlands (2%)
  • Canada (1%)
  • Sweden (1%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Therapeutics
  • Pharmaceutical
  • Medical Device
  • Software
  • Biopharma
  • Life Science
  • Manufacturing
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Sofinnova Partners frequently co-invest with?

Gimv
Europe, Antwerpen, Belgium, Antwerpen
Co-Investments: 16
Sofinnova Investments
North America, California, United States, Menlo Park
Co-Investments: 17
Pfizer Venture Investments
North America, New York, United States, New York
Co-Investments: 11
Forbion Capital Partners
Europe, Noord-Holland, The Netherlands, Naarden
Co-Investments: 11
Andera Partners
Europe, Ile-de-France, France, Paris
Co-Investments: 15
Novo Holdings
Europe, Hovedstaden, Denmark, Hellerup
Co-Investments: 12
SR One
North America, Massachusetts, United States, Cambridge
Co-Investments: 11
Bpifrance
Europe, Ile-de-France, France, Maisons-alfort
Co-Investments: 26
Gilde Healthcare
Europe, Utrecht, The Netherlands, Utrecht
Co-Investments: 11
Invus
North America, New York, United States, New York
Co-Investments: 15

Which angels does Sofinnova Partners often collaborate with?

YF
Europe, Ile-de-France, France, Paris
Shared Deals: 2
RL
North America, California, United States
Shared Deals: 2
FM
North America, California, United States, Mountain View
Shared Deals: 1
SS
North America, California, United States, Cupertino
Shared Deals: 2
CD
North America, New York, United States, New York
Shared Deals: 1
PB
Europe, Geneve, Switzerland, Geneva
Shared Deals: 1
JM
North America, California, United States, San Francisco
Shared Deals: 1
Shared Deals: 1
SL
Europe, Ile-de-France, France, Paris
Shared Deals: 2
NP
North America, California, United States, San Francisco
Shared Deals: 1

What are some of recent deals done by Sofinnova Partners?

Forth Therapeutics

Cambridge, Massachusetts, United States

Forth Therapeutics is a pioneering precision therapeutics that target the underlying mechanisms driving fibrosis.

Biotechnology
SeedMar 18, 2025

Signadori Bio is the next-generation cellular immunotherapy for cancer cure.

ManufacturingPharmaceutical
Series UnknownMar 18, 2025
GenSight Biologics

Paris, Ile-de-France, France

GenSight Biologics develops gene therapy-based treatments for retinal degenerative diseases.

BiotechnologyGeneticsHealth CareMedical
Post Ipo EquityMar 7, 2025
Amount Raised: $932,723
Latent Labs

London, England, United Kingdom

We are making biology programmable to transform health and sustainability for the benefit of all.

Artificial Intelligence (AI)BiotechnologyGenerative AILife SciencePharmaceutical
Series AFeb 13, 2025
Amount Raised: $40,000,000
Berry Street

New York, New York, United States

Berry Street offers treatment for disordered eating, heart health, PCOD, liver disease, women's health, sports nutrition, and diabetes.

FitnessHealth CareNutritionWellness
Series BFeb 5, 2025
Amount Raised: $50,000,000
Bioptimus

Paris, Ile-de-France, France

Bioptimus is an AI company that offers a foundation model for biology to fuel breakthrough discoveries and accelerate.

Artificial Intelligence (AI)BiotechnologyGenerative AI
Series AJan 14, 2025
Amount Raised: $41,000,000
Tenpoint Therapeutics

Camborne, Cornwall, United Kingdom

Tenpoint Therapeutics is a biotechnology company pursuing vision-restoring engineered cell-based therapeutics.

BiotechnologyProduct Research
Series UnknownDec 11, 2024
Noema Pharma

Basel, Basel-Stadt, Switzerland

Noema Pharma is a biotech company that develops therapies to address disabling symptoms in conditions of the brain and nervous system.

BiotechnologyMedicalPharmaceutical
Series BDec 11, 2024
Amount Raised: $30,567,953
nChroma Bio

Boston, Massachusetts, United States

nChroma Bio is a cutting-edge biotechnology business that is developing targeted in vivo delivery systems as well as best-in-class cargo.

BiotechnologyMedicalProduct Research
Series UnknownDec 11, 2024
Amount Raised: $75,000,000
Meiogenix

Paris, Ile-de-France, France

Meiogenix is a biotechnology company that develops breeding technologies.

BiotechnologyLife SciencePharmaceutical
Series ADec 1, 2024